326 related articles for article (PubMed ID: 8397916)
1. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
Winston DJ
Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of infection in bone marrow transplants.
Winston DJ; Ho WG; Gale RP; Champlin RE
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S15-23. PubMed ID: 3127217
[TBL] [Abstract][Full Text] [Related]
3. Current approaches to management of infections in bone marrow transplants.
Winston DJ; Ho WG; Champlin RE
Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S25-35. PubMed ID: 2693107
[TBL] [Abstract][Full Text] [Related]
4. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
Guglielmo BJ; Wong-Beringer A; Linker CA
Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
[TBL] [Abstract][Full Text] [Related]
5. The lung as a critical organ in marrow transplantation.
Quabeck K
Bone Marrow Transplant; 1994; 14 Suppl 4():S19-28. PubMed ID: 7728120
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection after bone marrow transplantation in children.
Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams.
Hoyle C; Goldman JM
Bone Marrow Transplant; 1994 Aug; 14(2):247-52. PubMed ID: 7994240
[TBL] [Abstract][Full Text] [Related]
9. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
Castagnola E; Bucci B; Montinaro E; Viscoli C
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
Winston DJ; Gale RP
Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
[TBL] [Abstract][Full Text] [Related]
12. [Primary and secondary prevention of cytomegalovirus infections in immunocompromised patients].
Salmon-Céron D
Ann Med Interne (Paris); 1997; 148(3):246-54. PubMed ID: 9255334
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in the bone marrow transplant recipient.
Zaia JA; Forman SJ
Infect Dis Clin North Am; 1995 Dec; 9(4):879-900. PubMed ID: 8747771
[TBL] [Abstract][Full Text] [Related]
14. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
[TBL] [Abstract][Full Text] [Related]
15. Infection after lung transplantation.
Paradis IL; Williams P
Semin Respir Infect; 1993 Sep; 8(3):207-15. PubMed ID: 8016481
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
Bass EB; Powe NR; Goodman SN; Graziano SL; Griffiths RI; Kickler TS; Wingard JR
Bone Marrow Transplant; 1993 Sep; 12(3):273-82. PubMed ID: 8241987
[TBL] [Abstract][Full Text] [Related]
17. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
[TBL] [Abstract][Full Text] [Related]
18. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
[TBL] [Abstract][Full Text] [Related]
20. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
